3DPrint.com July 7, 2025
TissueTinker is a McGill University startup that aims to accelerate cancer research. The team uses 3D printing to make tumor models from hydrogels. That approach may lead to alternatives for animal testing, which of course would alleviate a lot of suffering by animals. But at the same time, it could also make cancer research quicker and less expensive. The tumor models could also be more accurate, leading to faster adoption of new cancer drugs or better paths to cancer drugs. If TissueTinker demonstrates its ability to speed up preclinical trials, the firm could play a significant role in the future of cancer research.
Current animal-based testing and simplistic models of human organs and tumors are simply not effective in cost-effectively...
Today's Sponsors
Today's Sponsor